Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Psyence Group Inc (PSYGF)

Psyence Group Inc (PSYGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PSYGF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0116 +0.86%
on 06/24/24
0.0167 -29.94%
on 05/31/24
-0.0043 (-26.88%)
since 05/22/24
3-Month
0.0116 +0.86%
on 06/24/24
0.0224 -47.77%
on 04/17/24
-0.0264 (-69.29%)
since 03/20/24
52-Week
0.0116 +0.86%
on 06/24/24
0.2200 -94.68%
on 08/07/23
-0.1038 (-89.87%)
since 06/20/23

Most Recent Stories

More News
FILAMENT HEALTH AND PSYENCE ANNOUNCE WORLDWIDE LICENSING AGREEMENT OF PSILOCYBIN CAPSULE FOR PALLIATIVE CARE

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament"), a clinical-stage natural psychedelic drug development company, and Psyence...

FLHLF : 0.0335 (unch)
PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
Psyence Group Corporate Update

Highlights: Partnership with CRO Clerkenwell Health to design and deliver Psyence’s UK clinical trial progressing; exclusive licensing agreement with...

PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
Psyence Taps Another Pharma Exec to Drive its Clinical Program

TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products

The partnership leverages Psyence’s expertise in fungi cultivation and palliative care as well as Filament’s expertise in the manufacture of pharmaceutical...

PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
FILAMENT HEALTH AND PSYENCE ENTER INTO EXCLUSIVE LICENSING AGREEMENT FOR NATURAL PSILOCYBIN PRODUCTS

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company,...

FLHLF : 0.0335 (unch)
PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
Psyence looks to expand capital market opportunities in the UK and Europe

TORONTO, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
Psyence to Present at the H.C Wainwright 2nd Annual Psychedelics Conference December 6

TORONTO, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
Psyence Group Announces Private Placement

TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
Psyence Group Functional Mushroom Brand “GOODMIND™” Commences National Roll-Out in South Africa’s Largest Coffee Retail Chain

Company Broadens Revenue Generation Initiatives...

PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)
Psyence Group Inc. files Q2 Unaudited Condensed Consolidated Interim Financial Statements and MD&A

TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.0150 (+50.00%)
PSYGF : 0.0117 (-24.03%)

Key Turning Points

3rd Resistance Point 0.0132
2nd Resistance Point 0.0128
1st Resistance Point 0.0123
Last Price 0.0117
1st Support Level 0.0114
2nd Support Level 0.0110
3rd Support Level 0.0105

See More

52-Week High 0.2200
Fibonacci 61.8% 0.1404
Fibonacci 50% 0.1158
Fibonacci 38.2% 0.0912
Last Price 0.0117
52-Week Low 0.0116

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar